Jan 29, 2026
What randomized clinical trial evidence supports efficacy of hydromethylthionine (HMTM) at 8–16 mg/day versus placebo in Alzheimer's disease?
(HMTM, formerly LMTM) has produced mixed randomized trial evidence: large Phase III programs failed to show a simple dose‑response signal when high doses (150–250 mg/day) were compared with an 8 mg/da...